• News
  • Foundation to deepen its work moving pharma c...
News - published on 10 Jan 2022

Foundation to deepen its work moving pharma companies on access to diabetes care

Each year, more than 100,000 children and young adults are diagnosed with type 1 diabetes. Although the products that can keep them alive do exist, these are often out of reach for people living in low- and middle-income countries. In 2022, the Foundation will assess the best solutions for pharma companies to build sustainable and equitable access to diabetes care.

Explore further

Get in touch

Back to top |